Saturday, November 08, 2008
warfarin en PPI
SUMMARY AND COMMENT
Risk Factors for Recurrent GI Bleeding
November 7, 2008 | David J. Bjorkman, MD, MSPH (HSA), SM (Epid.)
Risk increased with use of oral warfarin and was reduced by use of a PPI, but not by use of a histamine-2–receptor antagonist.
Reviewing: Massó González EL and García Rodríguez LA. Aliment Pharmacol Ther 2008 Sep 1; 28:629
# posted by roodbont @ 10:53 AM 
